BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15525558)

  • 1. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
    Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
    J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability.
    Veyron-Churlet R; Guerrini O; Mourey L; Daffé M; Zerbib D
    Mol Microbiol; 2004 Dec; 54(5):1161-72. PubMed ID: 15554959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
    Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
    J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
    He X; Mueller JP; Reynolds KA
    Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
    Sachdeva S; Reynolds KA
    Methods Mol Med; 2008; 142():205-13. PubMed ID: 18437316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.
    Brown AK; Taylor RC; Bhatt A; Fütterer K; Besra GS
    PLoS One; 2009 Jul; 4(7):e6306. PubMed ID: 19609444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
    Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
    J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis.
    Bhatt A; Kremer L; Dai AZ; Sacchettini JC; Jacobs WR
    J Bacteriol; 2005 Nov; 187(22):7596-606. PubMed ID: 16267284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.
    Machutta CA; Bommineni GR; Luckner SR; Kapilashrami K; Ruzsicska B; Simmerling C; Kisker C; Tonge PJ
    J Biol Chem; 2010 Feb; 285(9):6161-9. PubMed ID: 20018879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.
    Sachdeva S; Musayev FN; Alhamadsheh MM; Scarsdale JN; Wright HT; Reynolds KA
    Chem Biol; 2008 Apr; 15(4):402-12. PubMed ID: 18420147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tail of mycolic acids.
    Lu JZ; Prigge ST
    Chem Biol; 2008 Apr; 15(4):309-10. PubMed ID: 18420136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation.
    Molle V; Brown AK; Besra GS; Cozzone AJ; Kremer L
    J Biol Chem; 2006 Oct; 281(40):30094-103. PubMed ID: 16873379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.